hotspot -WSS

hotspot

author：leisure time 2025-09-29 22:38:08 - browse：75872

A medical device to treat below-the-knee chronic limb-threatening ischemia, Esprit BTK resorbable scaffold, is shown consisted of pieces of geometric shapes that lined up into a pipe on a blue background — health tech coverage from STAT — Cardiovascular doctors are optimistic about Abbott’s new below-knee stent that disappears into the blood vessel’s walls over the course of three years. Courtesy Abbott

An Abbott device that failed in heart disease patients is getting a new life in patients with severe vascular disease.

The device is a below-knee stent that widens clogged blood vessels, and then vanishes into the vessel’s walls over the course of three years. It also delivers a drug that prevents scar tissue from forming — a common risk factor with traditional metal stents that further narrow the vessel.

Abbott’s first dissolvable stent, for coronary artery disease, received Food and Drug Administration approval in 2016. But the company voluntarily pulled the product from the market just over a year later due to “low commercial uptake.” The device also received mixed results in clinical trials.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum
Next article： Google says AlphaFold 3 can map a vast universe of biomolecules

hotspot

entertainment

WSS

New definition of a human embryo proposed amid rapid advances

What nurses really want: sufficient staffing for patient care

Use wet bulb globe temperature, not heat index, to protect workers

H5N1 bird flu: what we're starting to learn about infection in cows

Shionogi licenses Pompe disease therapy from Maze Therapeutics

The pain doctors face in trying to build their families

entertainment

hotspot

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

focus

As demand for Covid shots wanes, Moderna seeks its next success

Dairy farmers resist CDC push for PPE against bird flu virus

Tori Bowie and the unacceptable rates of Black maternal death

FDA approves first treatment for ultra

The cancer drug shortage isn’t new — and neither are the solutions

Beware the threat of staffing cuts at the CDC

Malaria cases in Florida and Texas: Here’s what you need to know

Apple Watch's A

How one medical school became remarkably diverse

Readout LOUD podcast: What to know about H5N1 bird flu

Wikipedia

Dairy farmers resist CDC push for PPE against bird flu virus

Researchers on aging grapple with how to calculate biological age

Cancer drug shortages' outsize impact on ovarian cancer patients

CDC wastewater surveillance dashboard to track bird flu hotspots

Beware the threat of staffing cuts at the CDC

Alcohol isn't healthy after all. Will new dietary guidelines reflect that?

knowledge

hotspot

entertainment

hotspot